The bottom line: We maintain our $200 fair value estimate for wide-moat Apple. We believe our long-term thesis for slowing ...

Chamunda Electricals is looking to raise a total of Rs 14.60 crore via IPO, which is entirely a fresh share sale of 29,19,000 ...

President Trump has moved to slash the federal workforce and spending. The Washington DC office market's recovery from the ...

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...

Palantir Technologies recently reported stellar fourth-quarter financial results that propelled its market value to $230 ...

But after Celsius was booted to the over-the-counter (OTC) markets, the company replaced its entire board and C-suite, rebranded and repackaged its drinks, and ended its unprofita ...

Align Technology reported earnings that aligned closely with expectations, highlighting international growth amid currency challenges.

Europe’s battery storage capacity is expected to grow around five-fold by 2030, bringing with it increasing returns for ...

The low turnover persisted in 2024, turning most intermediaries into losses, with many struggling to even pay employee salaries ...

Novo Nordisk (NVO), a pharmaceutical company, isn’t too worried about the U.S. government’s plan to negotiate prices for its ...

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.